MedTrace Logo

Rapid Assessment of Potential Ischaemic Heart Disease With CTCA

NCT02284191 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1749

Last updated 2024-08-21

Study results available
· View outcomes & findings →

Summary

This study aims to investigate the effect of early CTCA in patients with suspected or confirmed Acute Coronary Syndrome (ACS) presenting to the Emergency Department (ED) or Medical Assessment Unit (MAU), upon interventions, event rates and health care costs in a pragmatic clinical trial and economic evaluation up to 1 year after the trial intervention. The primary objective will be to investigate the effect of the intervention on all-cause death or subsequent type 1 or type 4b MI at one year, measured as time to first such event.

Conditions

  • Acute Coronary Syndrome

Interventions

RADIATION

CT Coronary Angiogram

Completion of a CT Coronary Angiogram

Sponsors & Collaborators

  • NHS Lothian

    collaborator OTHER_GOV

  • University of Edinburgh

    lead OTHER

Principal Investigators

  • Alasdair J Gray · NHS Lothian

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2020-06-30
Completion
2020-12-31

Countries

  • Jersey
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02284191 on ClinicalTrials.gov